Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-03-29 06:14 am Purchase |
2021-03-18 | 13G | Liquid Media Group Ltd. YVRLF |
Mitchell P. Kopin | 41,667 1.300% |
41,667![]() (New Position) |
Filing History |
2021-03-01 06:23 am Purchase |
2021-02-23 | 13G | Predictive Oncology Inc. POAI |
Mitchell P. Kopin | 173,847 7.400% |
173,847![]() (New Position) |
Filing History |
2021-02-25 4:22 pm Purchase |
2021-02-16 | 13G | ZW Data Action Technologies Inc. CNET |
Mitchell P. Kopin | 32,575 2.000% |
3,768![]() (+13.08%) |
Filing History |
2021-02-22 06:11 am Purchase |
2021-02-12 | 13G | Caladrius Biosciences, Inc. CLBS |
Mitchell P. Kopin | 63,307 1.600% |
63,307![]() (New Position) |
Filing History |
2021-02-22 06:08 am Purchase |
2021-02-12 | 13G | Antelope Enterprise Holdings Limited AEHL |
Mitchell P. Kopin | 199 7.900% |
199![]() (New Position) |
Filing History |
2021-02-19 4:24 pm Purchase |
2021-02-10 | 13G | Neovasc Inc. NVCN |
Mitchell P. Kopin | 96,391 3.500% |
45,000![]() (+87.56%) |
Filing History |
2021-02-18 4:18 pm Purchase |
2021-02-09 | 13G | Singularity Future Technology Ltd. SGLY |
Mitchell P. Kopin | 69,901 4.990% |
47,401![]() (+210.67%) |
Filing History |
2021-02-09 06:17 am Purchase |
2021-02-01 | 13G | CANCER GENETICS INC CGIX |
Mitchell P. Kopin | 710,905 9.990% |
710,905![]() (New Position) |
Filing History |
2021-02-08 06:10 am Purchase |
2021-02-02 | 13G | SenesTech, Inc. SNES |
Mitchell P. Kopin | 343 9.400% |
343![]() (New Position) |
Filing History |
2021-01-29 07:07 am Sale |
2020-12-31 | 13G | Ener-Core, Inc. ENCR |
Mitchell P. Kopin | 55,444 1.300% |
-280,500![]() (-83.50%) |
Filing History |
2021-01-29 07:06 am Purchase |
2020-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
Mitchell P. Kopin | 18,633 5.300% |
2,986![]() (+19.09%) |
Filing History |
2021-01-29 07:04 am Purchase |
2020-12-31 | 13G | Pulmatrix, Inc. PULM |
Mitchell P. Kopin | 118,500 6.400% |
59,844![]() (+102.03%) |
Filing History |
2021-01-29 07:03 am Sale |
2020-12-31 | 13G | Top Ships Inc. TOPS |
Mitchell P. Kopin | 75 0.040% |
-3,675![]() (-98.00%) |
Filing History |
2021-01-29 07:02 am Purchase |
2020-12-31 | 13G | Check-Cap Ltd. CHEK |
Mitchell P. Kopin | 154,070 6.200% |
129,845![]() (+536.00%) |
Filing History |
2021-01-29 07:00 am Purchase |
2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Mitchell P. Kopin | 514 3.500% |
514![]() (New Position) |
Filing History |
2021-01-29 06:58 am Purchase |
2020-12-31 | 13G | InspireMD, Inc. NSPR |
Mitchell P. Kopin | 96,511 3.800% |
70,070![]() (+265.00%) |
Filing History |
2021-01-29 06:56 am Sale |
2020-12-31 | 13G | Oragenics, Inc. OGEN |
Mitchell P. Kopin | 829 1.600% |
-1,023![]() (-55.25%) |
Filing History |
2021-01-29 06:54 am Sale |
2020-12-31 | 13G | Plus Therapeutics, Inc. PSTV |
Mitchell P. Kopin | 20,000 5.900% |
-7,039![]() (-26.03%) |
Filing History |
2021-01-29 06:53 am Sale |
2020-12-31 | 13G | Aethlon Medical, Inc. AEMD |
Mitchell P. Kopin | 2,239 1.500% |
-1,812![]() (-44.73%) |
Filing History |
2021-01-29 06:51 am Purchase |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Mitchell P. Kopin | 3,291,165 6.600% |
3,254,755![]() (+8939.10%) |
Filing History |